Search

Author/Creator Prada, Robier Aguillon

1. Canakinumab to reduce deterioration of cardiac and respiratory function in SARS‐CoV‐2 associated myocardial injury with heightened inflammation (canakinumab in Covid‐19 cardiac injury: The three C study). Issue 10 (24th August 2020)

Authors:
Sheng, Calvin C; Sahoo, Debasis; Dugar, Siddharth; Prada, Robier Aguillon; Wang, Tom Kai Ming; Abou Hassan, Ossama K; Brennan, Danielle; Culver, Daniel A; Rajendram, Prabalini; Duggal, Abhijit; Lincoff, A Michael; Nissen, Steven E; Menon, Venu; Cremer, Paul C
Journal:
Clinical cardiology
Issue:
Volume 43:Issue 10(2020)
Page Start:
1055
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Double-blind randomized proof-of-concept trial of canakinumab in patients with COVID-19 associated cardiac injury and heightened inflammation. Issue 1 (29th July 2021)

Authors:
Cremer, Paul C; Sheng, Calvin C; Sahoo, Debasis; Dugar, Siddharth; Prada, Robier Aguillon; Wang, Tom Kai Ming; Hassan, Ossama K Abou; Hernandez-Montfort, Jamie; Wolinsky, David A; Culver, Daniel A; Rajendram, Prabalini; Duggal, Abhijit; Brennan, Danielle M; Wolski, Katherine E; Lincoff, A Michael...
Journal:
European Heart Journal Open
Issue:
Volume 1:Issue 1(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search